Общественная организация "Здоровье. Информированный выбор!"

С вопросами и предложениями обращайтесь по адресам:
privivkam-net@yandex.ru
Сотрудничество, обмен баннерами и размещение рекламы на форуме >>
Финансовая помощь проекту >>
                    
Сообщения без ответов | Активные темы Текущее время: Пн май 25, 2020 9:14 am



Ответить на тему  [ Сообщений: 11 ] 
 Традиционная Китайская Медицина 
Автор Сообщение
Сообщение Традиционная Китайская Медицина
Внутренний Канон Желтого Владыки, часть Простые Вопросы. (Хуан Ди Нэй Цзин Су Вэнь) Том 1.
http://www.acupuncture.org.ru/neijing/neijing1.htm


Чт янв 18, 2007 5:40 pm
Сообщение 
Ссылка на прописи 200 препаратов Китайской Медицины на английском языке:
http://www.ccmp.gov.tw/en/information/f ... 52&level=C


Вс май 06, 2007 11:55 am
Сообщение 
Китайская Materia medica на английском языке:
http://www.tcmtreatment.com/Chinese-herbs.htm


Сб май 19, 2007 11:40 pm
Сообщение 
WARFARIN AND CHINESE MEDICINE.
Alternatives to warfarin are in advanced stages of drug research. One of the central problems with use of warfarin is its limited dosage range for therapeutic benefit and safety and its apparent susceptibility to interactions. These issues are related to the nature of the warfarin molecule, being somewhat similar to several naturally occurring compounds, and its interaction with at least six vitamin-K dependent clotting factors. As an example of a potential alternative, the drug ximelagatran (brand name: Exanta) is metabolized to yield melagatran, which inhibits only thrombin. This may allow patients to take a single prescribed dosage without having to frequently monitor the INR and adjust dosage; in addition, it appears to have a low level of interactions. As of this writing, the drug is not approved in the U.S., but is being used for some limited applications in Europe (short-term therapy for leg surgeries). A potential role for Chinese blood-vitalizing herbs will still be present even if this (or other alternatives to warfarin) provides a safer anticoagulant therapy.
http://www.itmonline.org/arts/warfarin.htm


Пн июн 11, 2007 1:49 pm
Сообщение 
Иллюстрированный атлас наиболее распространенных лекарств китайской медицины:
http://zhong-yi.narod.ru/atlas/index.html


Чт авг 16, 2007 1:44 am
Сообщение 
Прижигание в офтальмологии:
http://www.zhongyi.ru/forum/viewtopic.p ... highlight=


Сб сен 08, 2007 5:40 pm
Сообщение 
Прижигание слухового прохода:
http://www.zhongyi.ru/forum/viewtopic.p ... highlight=


Пн сен 10, 2007 7:28 pm
Сообщение 
Стандартный опросник сбора анамнеза для постановки диагноза Традиционной Китайской Медицины в электронном виде:
http://acupunctuur-ede.nl/user/brochure ... mulier.pdf
http://www.tcmtreatment.com/form.htm


Сб сен 15, 2007 7:33 pm
Модератор

Зарегистрирован: Пн фев 09, 2009 11:11 pm
Сообщений: 730
Откуда: Иркутск
Сообщение 
Хотя ни кому не интересно, продолжаю.
Stroke. 2009 Mar.
Danqi Piantang Jiaonang (DJ), a traditional Chinese medicine, in poststroke recovery.
Chen C, Venketasubramanian N, Gan RN, Lambert C, Picard D, Chan BP, Chan E, Bousser MG, Xuemin S.
Department of Pharmacology, National University of Singapore, Singapore. phccclh@nus.edu.sg
BACKGROUND AND PURPOSE: Stroke is a leading cause of death and disability worldwide. Despite improvements in acute stroke treatment, many patients only make a partial or poor recovery. Therefore, there is a need for treatments that would further improve outcome. Danqi Piantang Jiaonang (DJ; NeuroAid), a traditional Chinese medicine widely used in China to improve recovery after stroke, has been compared with another traditional Chinese medicine in 2 unpublished randomized clinical trials. The results of these studies were pooled and reanalyzed to assess efficacy and safety. METHODS: Six hundred five subjects were randomized in 2 randomized double-blinded, controlled trials to receive either DJ or Buchang Naoxintong Jiaonang. Subjects were treated for 1 month. Inclusion criteria were: (1) patients with recent (from 10 days to 6 months) ischemic stroke; (2) patients satisfying Western diagnostic standards for stroke and traditional Chinese medicine standards for diagnosis of apoplexy; and (3) Diagnostic Therapeutic Effects of Apoplexy score >/=10. RESULTS: The functional outcome, measured by the Comprehensive Function Score component of the Diagnostic Therapeutic Effects of Apoplexy scale, showed a statistically significant superiority of DJ over the control treatment group (relative risk, 2.4; 95% CI, 1.28 to 4.51; P=0.007). Tolerance was excellent in both groups. CONCLUSIONS: The pooled analysis of 2 unpublished trials of DJ, a traditional Chinese medicine currently approved in China to improve neurological recovery after stroke, shows good tolerability and superiority of DJ over another traditional Chinese medicine also approved for stroke. A large double-blind randomized clinical trial is required to further assess the safety and efficacy of DJ.
http://www.ncbi.nlm.nih.gov/pubmed/1916 ... d_RVDocSum

Cerebrovasc Dis. 2008 Apr 16.
Erratum in: Cerebrovasc Dis. 2009.
Danqi Piantan Jiaonang does not modify hemostasis, hematology, and biochemistry in normal subjects and stroke patients.
Gan R, Lambert C, Lianting J, Chan ES, Venketasubramanian N, Chen C, Chan BP, Samama MM, Bousser MG.
Department of Neurology, National Neuroscience Institute, Singapore, Singapore. robert_gan@nni.com.sg
BACKGROUND AND OBJECTIVE: Previous studies on Danqi Piantan Jiaonang (DPJ, NeuroAid), a traditional Chinese medicine, in stroke patients showed promising results. Our aim was to determine the safety of DPJ in normal subjects and stroke patients through a series of studies assessing its immediate and long-term effects, alone and in combination with aspirin, on hematological, hemostatic, and biochemical parameters. METHODS: We conducted 3 studies from December 2004 to May 2006. Study 1 was a case series which recruited 32 healthy volunteers who were given 2 oral doses of 4 DPJ capsules (0.4 g/capsule) 6 h apart. Study 2 was a randomized controlled trial of 22 healthy volunteers who received either 1 oral dose of aspirin 300 mg alone or a combination of 1 dose of aspirin 300 mg and 2 doses of 4 DPJ capsules taken 6 h apart. For both studies 1 and 2, hemostatic parameters (prothrombin time, activated partial thromboplastin time, fibrinogen, platelet aggregation, D-dimer) were tested at baseline, and after 2 and 8 h. Study 3 was a case series which recruited 10 patients with recent ischemic stroke (within 7 days) who were given 4 DPJ capsules taken orally 3 times a day for 1 month. Blood tests for hemostatic, hematological (complete blood count), and biochemical parameters (glucose, creatinine, alanine aminotransferase, aspartate transaminase, C-reactive protein) were performed at baseline, and after 1 and 4 weeks. RESULTS: Apart from the expected changes in platelet aggregation in subjects taking aspirin, no significant differences were detected in hemostatic parameters at baseline, and 2 and 8 h after oral intake of DPJ alone or in combination with aspirin. Likewise, no significant differences were observed in hematological, hemostatic, and biochemical parameters at baseline, and after 1 and 4 weeks of oral intake of DPJ. CONCLUSION: DPJ does not significantly modify hematological, hemostatic, and biochemical parameters in normal subjects and stroke patients. (c) 2008 S. Karger AG, Basel.
http://www.ncbi.nlm.nih.gov/pubmed/1841 ... d_RVDocSum

J. Tradit Chin Med. 2005 Sep.
A clinical study on the treatment of urinary infection with Zishen Tongli Jiaonang.
Zhang M, Zhang D, Xu Y, Duo X, Zhang W.
Gong An Hospital, Tianjin 300050, China.
OBJECTIVE: To observe the therapeutic effects of Zishen Tongli Jiaonang (capsules for nourishing the kidney and promoting urination) for treatment of urinary infection. METHOD: The treatment group with a control group were randomly set up. 120 patients in the control group were given antibiotics according to drug sensitive tests for orally taking or intravenous drip, while 136 patients in the treatment group were additionally given the capsules on the basis of the above-mentioned treatment. One course of treatment lasted 2 weeks. Statistical analysis on the therapeutic effects was conducted after a two-course treatment. The recurrence rates of the two groups were compared one year later. RESULTS: The total remission rates were respectively 96.3% in the treatment group and 81.7% in the control group (P<0.05). The recurrence rates one year later were respectively 4.4% in the treatment group and 30.0% in the control group (P<0.01). CONCLUSION: The capsules show good effects for urinary infection, especially in the long-term effect.
http://www.ncbi.nlm.nih.gov/pubmed/1633 ... d_RVDocSum


Вс сен 27, 2009 3:47 pm
Профиль WWW
Модератор

Зарегистрирован: Пн фев 09, 2009 11:11 pm
Сообщений: 730
Откуда: Иркутск
Сообщение Re: Традиционная Китайская Медицина
Neuropharmacology. 2013 Feb;65:1-11. doi: 10.1016/j.neuropharm.2012.09.001. Epub 2012 Sep 10.
Alpha-asarone from Acorus gramineus alleviates epilepsy by modulating A-Type GABA receptors.
Huang C, Li WG, Zhang XB, Wang L, Xu TL, Wu D, Li Y.
Source
Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China; Neuroscience Division, Department of Biochemistry and Molecular Cell Biology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Shanghai 200025, China.
Abstract.
Alpha (α)-asarone is a major effective compound isolated from the Chinese medicinal herb Acorus gramineus, which is widely used in clinical practice as an antiepileptic drug; however, its mechanism of action remains unclear. In this study, we have characterized the action of α-asarone on the excitability of rat hippocampal neurons in culture and on the epileptic activity induced by pentylenetetrazole or kainate injection in vivo. Under cell-attached configuration, the firing rate of spontaneous spiking was inhibited by application of α-asarone, which was maintained in the Mg(2+)-free solution. Under whole-cell configuration, α-asarone induced inward currents in a concentration-dependent manner with an EC(50) of 248 ± 33 μM, which was inhibited by a GABA(A) receptor blocker picotoxin and a competitive GABA(A) receptor antagonist bicuculline but not a specific glycine receptor inhibitor strychnine. Measurement of tonic GABA currents and miniature spontaneous inhibitory postsynaptic currents indicated that α-asarone enhanced tonic GABAergic inhibition while left phasic GABAergic inhibition unaffected. In both pentylenetetrazole and kainate seizure models, α-asarone suppressed epileptic activity of mice by prolonging the latency to clonic and tonic seizures and reducing the mortality as well as the susceptibility to seizure in vivo presumably dependent on the activation of GABA(A) receptors. In summary, our results suggest that α-asarone inhibits the activity of hippocampal neurons and produces antiepileptic effect in central nervous system through enhancing tonic GABAergic inhibition.
http://www.ncbi.nlm.nih.gov/pubmed/22975146


Ср янв 02, 2013 3:48 pm
Профиль WWW
Модератор

Зарегистрирован: Пн фев 09, 2009 11:11 pm
Сообщений: 730
Откуда: Иркутск
Сообщение Re: Традиционная Китайская Медицина
Нашел китайскую мазилу от рубцов. Что увидел на картинках, впечатляет.
Изображение
http://quba.actsat.org/
Вот только не силен в китайском, нужно перевести состав, из чего сделана мазь. Неоднократно встречался с фактами, когда за мудреными китайскими иероглифами встречаются не совсем полезные компоненты.


Пт авг 29, 2014 1:32 pm
Профиль WWW
Показать сообщения за:  Сортировать по:  
Ответить на тему   [ Сообщений: 11 ] 

Кто сейчас на форуме

Сейчас этот форум просматривают: нет зарегистрированных пользователей и гости: 2


Вы не можете начинать темы
Вы не можете отвечать на сообщения
Вы не можете редактировать свои сообщения
Вы не можете удалять свои сообщения
Вы не можете добавлять вложения

Найти:
Перейти:  
cron

Техническая поддержка CYGNUS HOSTING

Мы в Твиттере
Powered by phpBB © 2000, 2002, 2005, 2007 phpBB Group.
Designed by STSoftware for PTF.
Русская поддержка phpBB